 |
 |

Copper Balance Studies In Wilson's DiseaseObservations on the Effect of Penicillamine, Carbacrylamine Resins, and Potassium Sulfide
NORMAN P. GOLDSTEIN, MD;
RAYMOND V. RANDALL, MD;
JOHN B. GROSS, MD;
WARREN F. McGUCKIN, PhD
Arch Neurol. 1965;12(5):456-462.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
A LTHOUGH it is generally recognized that Wilson's disease (hepatolenticular degeneration) is a genetic disorder involving a disturbance of the metabolism of copper, there are few reports related to studies of copper balance.1-3 Available data indicate that patients who have this disorder absorb greater than normal amounts of copper from the gastrointestinal tract4 and excrete less than normal amounts in the feces.5 However, the mechanisms of intestinal absorption and fecal excretion of copper remain obscure, both in normal individuals and in patients with this illness.
The treatment of Wilson's disease with penicillamine is known to increase the urinary excretion of copper.6,7 Likewise, it has been stated that the oral use of either ion-exchange resins8,9 or potassium sulfide10,11 at mealtime increases the fecal content of copper. In view of the derangement of copper metabolism in this illness, treatment should be aimed at achieving a negative
. . . [Full Text PDF of this Article]
Author Affiliations
ROCHESTER. MINN
From the Mayo Clinic and Mayo Foundation. Section of Neurology (Dr. Goldstein); Section of Medicine (Drs. Randall and Gross); Section of Biochemistry (Dr. McGuckin).
Footnotes
Submitted for publication April 15, 1964; accepted Jan 11, 1965.
Read by title at the meeting of the American Neurological Association, Atlantic City, NJ, June 10-12, 1963.
Reprint requests to Mayo Clinic, Rochester, Minn 55901.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|